Recent research has unveiled a significant link between a condition known as metabolic dysfunction-associated steatotic liver disease (MASLD), formerly termed non-alcoholic fatty liver disease (NAFLD), and an increased risk of heart failure. This condition is not caused by heavy alcohol consumption and is becoming a widespread global health concern, impacting an estimated 30.2% of people worldwide. Alarmingly, this figure rises to over 40% in regions like the Americas and Southeast Asia.
MASLD often goes unnoticed as it frequently presents no symptoms. However, it can lead to severe complications, including liver inflammation, scarring, and even liver cancer. Health experts are increasingly recognizing that MASLD is not just a liver problem but also poses serious risks to heart health. A study conducted by Duke University tracked 570 adults with confirmed MASLD over a median of 11 years. The findings revealed that nearly 18% of these individuals developed heart failure, and about 48% showed signs of potential heart issues that had gone undiagnosed.
This research highlights a blind spot in the healthcare system: many individuals with fatty liver disease are not being screened for heart conditions, leading to missed opportunities for early intervention. The American Heart Association has emphasized that heart disease is now a leading cause of death among those with MASLD, surpassing complications related to liver disease.
Data from a major meta-analysis involving over 11 million people indicate that NAFLD increases the risk of developing heart failure by 1.5 times, irrespective of other factors like age or obesity. The shared risk factors between MASLD and cardiovascular problems include insulin resistance, obesity, and chronic inflammation. Inflammation from fat-laden liver cells can damage blood vessels and contribute to worsening heart function, making early detection and management of MASLD essential.
To mitigate these risks, experts recommend that adults diagnosed with MASLD, especially those with conditions such as diabetes or high cholesterol, undergo screenings for heart issues. Clinical guidelines suggest treating both liver and heart conditions together using certain medications that can improve outcomes by reducing inflammation.
Overall, fatty liver disease poses a dual threat to health, impacting not just the liver but also significantly increasing the risk of heart issues. Regular screenings and lifestyle modifications are crucial for managing these interconnected problems. If you or someone you know is at risk, consulting a healthcare provider is vital, as understanding liver health may be key to protecting heart health.
-Rashmi Kumari
